Despite the promising potential, several challenges remain:
Specificity: Ensuring that therapeutic interventions target only HOTAIR without affecting other lncRNAs or essential genes is crucial. Delivery: Effective delivery mechanisms are needed to ensure that therapeutic agents reach cancer cells in sufficient concentrations. Resistance: Cancer cells may develop resistance to therapies targeting HOTAIR, necessitating combination therapies or alternative strategies.
